Sangro, Bruno http://orcid.org/0000-0002-4177-6417
Sarobe, Pablo http://orcid.org/0000-0003-0503-7905
Hervás-Stubbs, Sandra http://orcid.org/0000-0003-3391-1516
Melero, Ignacio http://orcid.org/0000-0002-1360-348X
Article History
Accepted: 5 March 2021
First Online: 13 April 2021
Competing interests
: I.M. reports advisory roles with Roche-Genentech, Bristol-Myers Squibb, CYTOMX, Incyte, MedImmune, Tusk, F-Star, Genmab, Molecular Partners, Alligator, Bioncotech, MSD, Merck Serono, Boehringer Ingelheim, Astra Zeneca, Numab, Catalym and Bayer, and research funding from Roche, BMS, Alligator and Bioncotech. B.S. reports consultancy fees from Adaptimmune, Astra Zeneca, Bayer, BMS, BTG, Eli Lilly, Ipsen, Novartis, Merck, Roche, Sirtex Medical and Terumo and speaker fees from Astra Zeneca, Bayer, BMS, BTG, Eli Lilly, Ipsen, Novartis, Merck, Roche, Sirtex Medical, Terumo BMS and Sirtex Medical. P.S. and S.H.-S. report no competing interests.
Free to read: This content has been made available to all.